Search research articles
Contact Us
Filters
Showing results (71-80 of 127) with videos related to
Page
of 13
Sort By:
European Urology
|
November 27, 2012
Dutasteride treatment over 2 years delays prostate-specific antigen progression in patients with biochemical failure after radical therapy for prostate cancer: results from the randomised, placebo-controlled Avodart After Radical Therapy for Prostate Cancer Study (ARTS)
Fritz Schröder, Chris Bangma, Javier C Angulo, et al.
Scandinavian Journal of Urology
|
September 13, 2017
Prediction of infection caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae: development of a clinical decision-making nomogram
Ana García-Tello, Helena Gimbernat, Cristina Redondo, et al.
Cold Spring Harbor Perspectives in Medicine
|
September 11, 2019
Precise Immunodetection of PTEN Protein in Human Neoplasia
Rafael Pulido, Janire Mingo, Ayman Gaafar, et al.
The Journal of Urology
|
September 19, 2009
Clinicopathological study of regressed testicular tumors (apparent extragonadal germ cell neoplasms)
Javier C Angulo, Javier González, Nuria Rodríguez, et al.
Urology
|
August 23, 2021
Adjustable Transobturator Male System (ATOMS) Infection: Causative Organisms and Clinical Profile
Javier C Angulo, Keith Rourke, Fabian Queissert, et al.
European Urology
|
March 30, 2013
Efficacy and safety of solifenacin plus tamsulosin OCAS in men with voiding and storage lower urinary tract symptoms: results from a phase 2, dose-finding study (SATURN)
Philip Van Kerrebroeck, François Haab, Javier C Angulo, et al.
European Urology
|
July 3, 2013
Reply from authors re: Apostolos Apostolidis. Male lower urinary tract symptoms: a riddle waiting to be solved. Eur Urol 2013;64:408-10: a rationale for combination antimuscarinic-α-blocker therapy for male lower urinary tract symptoms
Philip Van Kerrebroeck, François Haab, Javier C Angulo, et al.
International Journal of Molecular Sciences
|
January 8, 2023
Claudin-3 Loss of Expression Is a Prognostic Marker in Castration-Resistant Prostate Cancer
María J Orea, Javier C Angulo, Ana González-Corpas, et al.
Journal of Clinical Medicine
|
August 26, 2022
ATOMS (Adjustable Trans-Obturator Male System) in Patients with Post-Prostatectomy Incontinence and Previously Treated Urethral Stricture or Bladder Neck Contracture
Ane Ullate, Ignacio Arance, Miguel Virseda-Chamorro, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease
|
August 23, 2023
Protein kinase D activity is a risk biomarker in prostate cancer that drives cell invasion by a Snail/ERK dependent mechanism
Darío Cilleros-Rodríguez, María Val Toledo-Lobo, Desirée Martínez-Martínez, et al.
Page
of 13
Search research articles
Search
Showing results (71-80 of 127) with videos related to
Sort By:
Page
of 13
European Urology
|
November 27, 2012
Dutasteride treatment over 2 years delays prostate-specific antigen progression in patients with biochemical failure after radical therapy for prostate cancer: results from the randomised, placebo-controlled Avodart After Radical Therapy for Prostate Cancer Study (ARTS)
Fritz Schröder, Chris Bangma, Javier C Angulo, et al.
Scandinavian Journal of Urology
|
September 13, 2017
Prediction of infection caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae: development of a clinical decision-making nomogram
Ana García-Tello, Helena Gimbernat, Cristina Redondo, et al.
Cold Spring Harbor Perspectives in Medicine
|
September 11, 2019
Precise Immunodetection of PTEN Protein in Human Neoplasia
Rafael Pulido, Janire Mingo, Ayman Gaafar, et al.
The Journal of Urology
|
September 19, 2009
Clinicopathological study of regressed testicular tumors (apparent extragonadal germ cell neoplasms)
Javier C Angulo, Javier González, Nuria Rodríguez, et al.
Urology
|
August 23, 2021
Adjustable Transobturator Male System (ATOMS) Infection: Causative Organisms and Clinical Profile
Javier C Angulo, Keith Rourke, Fabian Queissert, et al.
European Urology
|
March 30, 2013
Efficacy and safety of solifenacin plus tamsulosin OCAS in men with voiding and storage lower urinary tract symptoms: results from a phase 2, dose-finding study (SATURN)
Philip Van Kerrebroeck, François Haab, Javier C Angulo, et al.
European Urology
|
July 3, 2013
Reply from authors re: Apostolos Apostolidis. Male lower urinary tract symptoms: a riddle waiting to be solved. Eur Urol 2013;64:408-10: a rationale for combination antimuscarinic-α-blocker therapy for male lower urinary tract symptoms
Philip Van Kerrebroeck, François Haab, Javier C Angulo, et al.
International Journal of Molecular Sciences
|
January 8, 2023
Claudin-3 Loss of Expression Is a Prognostic Marker in Castration-Resistant Prostate Cancer
María J Orea, Javier C Angulo, Ana González-Corpas, et al.
Journal of Clinical Medicine
|
August 26, 2022
ATOMS (Adjustable Trans-Obturator Male System) in Patients with Post-Prostatectomy Incontinence and Previously Treated Urethral Stricture or Bladder Neck Contracture
Ane Ullate, Ignacio Arance, Miguel Virseda-Chamorro, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease
|
August 23, 2023
Protein kinase D activity is a risk biomarker in prostate cancer that drives cell invasion by a Snail/ERK dependent mechanism
Darío Cilleros-Rodríguez, María Val Toledo-Lobo, Desirée Martínez-Martínez, et al.
Page
of 13